Home / Find a Study

Ulcerative Colitis (IQVIA)

#

Ulcerative Colitis (IQVIA)

  • Compensation to be determined
  • 13 visits (enrollment open)
#

18+ Years

#
Male or Female
#
Smoker & Non-Smoker
# Share Refer a Friend

Description

A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis.

Is this not what you are looking for?
Check out our other studies.

Find a Study

Related Studies

#

Atopic Dermatitis

  • Compensation to be determined
  • 8 clinic visits and 2 phone visits
#

A. ≥ 12yo to <18, weight > 40kg (adolescent group)
B. ≥ 18yo (adult group)

#
Male or Female
#
Smoker & Non-Smoker
#

Ulcerative Colitis (IQVIA)

  • Compensation to be determined
  • clinic visits 10
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
#

Ulcerative Colitis (InDex)

  • Compensation to be determined
  • clinic visits 10
#
18+ Years

#
Male or Female
#
Smoker & Non-Smoker
© 2023 Access Research Institute. All Rights Reserved
✖